Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG

Cancer stem cells (CSCs) have been identified as the source of tumor growth and disease recurrence. Eradication of CSCs is thus essential to achieve durable responses, but CSCs are resistant to current anti-tumor therapies. Novel therapeutic approaches that specifically target CSCs will, therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wefers, Christina, Schreibelt, Gerty, Massuger, Leon F. A. G., de Vries, I. Jolanda M., Torensma, Ruurd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018198/
https://www.ncbi.nlm.nih.gov/pubmed/29971070
http://dx.doi.org/10.3389/fimmu.2018.01412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018198/
https://www.ncbi.nlm.nih.gov/pubmed/29971070
http://dx.doi.org/10.3389/fimmu.2018.01412

Ejemplares similares